Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 28, 2011; 17(12): 1631-1641
Published online Mar 28, 2011. doi: 10.3748/wjg.v17.i12.1631
Published online Mar 28, 2011. doi: 10.3748/wjg.v17.i12.1631
Figure 4 Frequencies of trefoil factor immunostaining in normal bile ducts, dysplasia and cholangiocarcinoma.
A: Trefoil factor (TFF)1 positive immunostaining was markedly frequent in dysplasia and cholangiocarcinoma (CCA) compared to normal; B: Frequency of TFF2 positive immunostaining was significantly higher in CCA than in dysplasia and normal controls; C: TFF3 positive immunostaining was less frequent in CCA than in dysplasia and controls. aP < 0.05.
- Citation: Kosriwong K, Menheniott TR, Giraud AS, Jearanaikoon P, Sripa B, Limpaiboon T. Trefoil factors: Tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma. World J Gastroenterol 2011; 17(12): 1631-1641
- URL: https://www.wjgnet.com/1007-9327/full/v17/i12/1631.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i12.1631